Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02383
Species: Homo sapiens
Position : chr3:185824281-185824602
Year: 2024
Title: KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: tongue squamous cell carcinoma
PMID:  38443991
MONDO: MONDO:0000500
Tissue: tongue
Tissue Ontology ID: UBERON:0001723
Cell Source: CAL-27
CVCL ID: CVCL_1107
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay; Enhancer activity assay; Endogenous enhancer perturbation; TF binding assay; Chromatin-state profiling; In vivo functional validation
High Throughput Method: ChIP-seq
Low Throughput Method: Luciferase Reporter Assay, ChIP-RT-qPCR, RT-RT-qPCR, Western blot; CRISPR-Cas9 endogenous deletion/editing; Luciferase reporter assay; ChIP-qPCR; ChIP; In vivo phenotyping; Xenograft/xenotransplant; Reporter assay
About Target Gene
Target gene : IGF2BP2
About TF
TF name : KLF7
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
KLF7 Hs_Cytokines_and_Inflammatory_Response_WP530_79331 wikipathways 21
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer